ROOT OF SKIN™ Skincare Line Sets New Sales Record on QVC Japan
IRVINE, Calif. – March 4, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that the Company’s revolutionary stem-cell based ROOT OF SKIN™ skincare line sold out in its 6th and 7th appearance on the Japanese home shopping channel QVC Japan. ROOT OF SKIN™ has sold out in every previous appearance on QVC Japan. The most recent 2 segments selling ROOT OF SKIN™ Revitalizing Face Renewal Serum and ROOT OF SKIN™ Revitalizing Eye Renewal Complex aired on Feb. 26 and 28th 2019, with sales exceeding QVC Japan targets.
ROOT OF SKIN™ is AIVITA’s proprietary skincare line for skin rejuvenation, made possible through the same proprietary knowledge and expertise used to develop its cutting-edge stem cell therapies. The all-new actives complex SourceCode Technology™ contains the complete set of factors and supporting biological components present in young, healthy skin.
“Following several successful sell-outs we’ve increased the available product inventory to meet the demand of Japanese QVC shoppers, and we’re thrilled to have exceeded even those expectations,” said Christi Douglass, AIVITA’s Marketing and Business Development Officer.
AIVITA Biomedical uses 100% of the proceeds from ROOT OF SKIN™ sales to support the treatment of women with ovarian cancer.
About ROOT OF SKIN™
ROOT OF SKIN™ is a rejuvenating line of skincare products fueled by an unrelenting pursuit for advancements in life-changing and life-saving treatments. Harnessing breakthroughs in stem cell therapy, AIVITA Biomedical developed a technology that does more than just boost regeneration. The patented actives complex SourceCode Technology™ renews, repairs and protects, just as your skin did at its youngest and healthiest stage. Rich with every biological component healthy skin needs for development, and free of any unnecessary ingredients. All proceeds support treatment of women with ovarian cancer.
About AIVITA Biomedical
AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its therapeutic pipeline and commercial line of skin care products.